Medadvisor Ltd (MDR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medadvisor Ltd (MDR) has a cash flow conversion efficiency ratio of 5.093x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-8.24 Million ≈ $-5.83 Million USD) by net assets (AU$-1.62 Million ≈ $-1.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Medadvisor Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Medadvisor Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Medadvisor Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medadvisor Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medadvisor Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Transkon Jaya Pt
JK:TRJA
|
0.054x |
|
Euroland Corporate SA
PA:MLERO
|
N/A |
|
Intensity Therapeutics, Inc. Common stock
NASDAQ:INTS
|
-0.183x |
|
Aakash Exploration Services Limited
NSE:AAKASH
|
0.010x |
|
TWZ Corporation Public Company Limited
BK:TWZ
|
-0.005x |
|
CalciMedica, Inc. Common Stock
NASDAQ:CALC
|
0.731x |
|
Meta Epsi Tbk PT
JK:MTPS
|
0.244x |
|
Capital Gearing Trust
LSE:CGT
|
0.006x |
Annual Cash Flow Conversion Efficiency for Medadvisor Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Medadvisor Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see MDR company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$-1.62 Million ≈ $-1.14 Million |
AU$-14.37 Million ≈ $-10.16 Million |
8.880x | +8729.14% |
| 2024-06-30 | AU$51.58 Million ≈ $36.50 Million |
AU$5.19 Million ≈ $3.67 Million |
0.101x | +435.19% |
| 2023-06-30 | AU$48.46 Million ≈ $34.29 Million |
AU$-1.45 Million ≈ $-1.03 Million |
-0.030x | -338.61% |
| 2022-06-30 | AU$34.55 Million ≈ $24.44 Million |
AU$-236.32K ≈ $-167.21K |
-0.007x | +97.34% |
| 2021-06-30 | AU$48.85 Million ≈ $34.56 Million |
AU$-12.54 Million ≈ $-8.88 Million |
-0.257x | +49.65% |
| 2020-06-30 | AU$17.02 Million ≈ $12.04 Million |
AU$-8.68 Million ≈ $-6.14 Million |
-0.510x | +36.52% |
| 2019-06-30 | AU$8.64 Million ≈ $6.12 Million |
AU$-6.95 Million ≈ $-4.91 Million |
-0.803x | -272.90% |
| 2018-06-30 | AU$15.17 Million ≈ $10.73 Million |
AU$-3.27 Million ≈ $-2.31 Million |
-0.215x | +16.19% |
| 2017-06-30 | AU$9.35 Million ≈ $6.62 Million |
AU$-2.40 Million ≈ $-1.70 Million |
-0.257x | +75.12% |
| 2016-06-30 | AU$2.46 Million ≈ $1.74 Million |
AU$-2.55 Million ≈ $-1.80 Million |
-1.033x | -123.13% |
| 2015-06-30 | AU$-106.88K ≈ $-75.63K |
AU$-477.40K ≈ $-337.79K |
4.467x | +155.67% |
| 2014-06-30 | AU$310.98K ≈ $220.04K |
AU$-2.50 Million ≈ $-1.77 Million |
-8.024x | -2576.88% |
| 2013-06-30 | AU$11.11 Million ≈ $7.86 Million |
AU$-3.33 Million ≈ $-2.36 Million |
-0.300x | -44.27% |
| 2012-06-30 | AU$2.78 Million ≈ $1.97 Million |
AU$-577.73K ≈ $-408.78K |
-0.208x | -5068.77% |
| 2011-06-30 | AU$3.14 Million ≈ $2.22 Million |
AU$-12.62K ≈ $-8.93K |
-0.004x | -- |
About Medadvisor Ltd
Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anm… Read more